Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hartnup disease
Comorbidity C0003873|rheumatoid arthritis
Sentences 33
PubMedID- 24825074 Circulating plasma levels of cathepsin s and l are not associated with disease severity in patients with rheumatoid arthritis.
PubMedID- 22403639 Illustrating this, we recently found, in women with rheumatoid arthritis, fluctuating levels of mc coinciding with disease flare up and treatment [34].
PubMedID- 24057092 Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
PubMedID- 23532497 Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis.
PubMedID- 22029973 Introduction: calprotectin (mrp8/mrp14, s100a8/a9) is associated with disease activity in patients with rheumatoid arthritis (ra).
PubMedID- 23786438 High frequencies of activated b cells and t follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis.
PubMedID- 20032101 Objective: to assess whether serum levels of cc and cxc chemokines correlate with disease activity in patients with rheumatoid arthritis (ra), and to determine whether these effects predict clinical response.
PubMedID- 25889060 Introduction: a higher prevalence of metabolic syndrome (mets) has been described in rheumatoid arthritis (ra), along with an association with disease activity.
PubMedID- 24702489 Decrease in serum interleukin-21 levels is associated with disease activity improvement in patients with recent-onset rheumatoid arthritis.
PubMedID- 22699077 [association of circulating treg cells with disease activity in patients with rheumatoid arthritis].
PubMedID- 20158894 Associations of endothelial progenitor cell (epc) levels in rheumatoid arthritis (ra) with disease activity.
PubMedID- 20881757 Objectives: (1) to determine 6-month follow-up adherence and persistence with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis with disease under control.
PubMedID- 25889527 Treating rheumatoid arthritis (ra) with disease modifying anti-rheumatic drugs (dmards) according to a treat-to-target (t2t) strategy is more effective than traditional routine care [1-5].
PubMedID- 23301223 Elevated levels of t helper 17 cells are associated with disease activity in patients with rheumatoid arthritis.
PubMedID- 23949637 Reduced numbers of regulatory b cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis.
PubMedID- 25900081 Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
PubMedID- 26339140 Progranulin is associated with disease activity in patients with rheumatoid arthritis.
PubMedID- 25279018 Serum adenosine deaminase level is high but not related with disease activity parameters in patients with rheumatoid arthritis.
PubMedID- 21303509 Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis.
PubMedID- 26064964 The objective of this study is to examine and evaluate whether serum 25(oh)d is associated with disease activity in patients with rheumatoid arthritis (ra).
PubMedID- 23897768 Association of circulating mir-223 and mir-16 with disease activity in patients with early rheumatoid arthritis.
PubMedID- 25458025 Objectives: this study aims to investigate the relationship of hemoglobin level with disease activity in patients with rheumatoid arthritis (ra).
PubMedID- 23044162 Nutritional status in relation to adipokines and oxidative stress is associated with disease activity in patients with rheumatoid arthritis.
PubMedID- 26064129 Definitive treatment for rheumatoid arthritis begins with disease-modifying antirheumatic drugs (dmards) such as methotrexate (mtx).
PubMedID- 25729037 Surface april is elevated on myeloid cells and is associated with disease activity in patients with rheumatoid arthritis.
PubMedID- 20232340 Immunodominant t-cell epitopes of hnrnp-a2 associated with disease activity in patients with rheumatoid arthritis.
PubMedID- 20371432 Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis.
PubMedID- 23983001 Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
PubMedID- 25249397 We here examine the role of cxcl13 and its association with disease in patients with treatment-naive early rheumatoid arthritis.
PubMedID- 26087054 Aim: to investigate the presence of autoantibodies (aabs) against interleukin (il)-17a and il-17f and observe whether anti-il-17a or il-17f aabs are associated with disease activity in patients with early rheumatoid arthritis (era).
PubMedID- 21921095 Cd4+cd25(high)cd127(low/-) treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis.
PubMedID- 22391859 Color flow signals of six-joint doppler sonography correlate with disease activity in patients with rheumatoid arthritis.
PubMedID- 24942540 Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.

Page: 1